Argenx
ARGX----
Argenx (ARGX)
argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Net...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Argenx Analyst Rating
View MoreForecast & Rating
Jul 24, 2026Price forecast
$1081.9617.83%
Forecast & RatingBuy
25analysts
- Strong buy60.00%
- Buy28.00%
- Hold8.00%
- Sell0.00%
- Strong sell4.00%
News
- Simplywall · 1 day ago, 04:17 PM
Argenx (ENXTBR:ARGX) Stock Faces Margin Compression As 32.3% Profitability Tests Bullish Narrative
- Market Beat · 1 day ago, 11:18 AM
argenex (NASDAQ:ARGX) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says
- Tip Ranks · 1 day ago, 01:06 AM
Jefferies Reaffirms Their Buy Rating on arGEN X (0QW0)
- Price Alert · 2 days ago, 02:18 PM
U.S. stock market midday update: Argenx's earnings report exceeded expectations, rising 7.46%, analysts support target price
- Quartr · 2 days ago, 10:04 AM
ARGX: Q2 revenue up 60% YoY, VYVGART expands in MG/CIDP, pipeline and financials remain strong
- Tip Ranks · 2 days ago, 08:36 AM
Bernstein Keeps Their Buy Rating on arGEN X (0QW0)
